Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | 7 | 1 | 2 | 0 | €113.00 | €147.62 | 30.634% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €11.33 | €27.80 | 145.402% |
| Smith & Nephew plc ADR | 2 | 0 | 0 | 0 | €23.40 | - | - |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.077 | - | - |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.34 | €8.36 | 150.006% |
| Adocia | 1 | 0 | 0 | 0 | €9.40 | €20.00 | 112.766% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €29.20 | €41.81 | 43.199% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Radnet Inc. | 8 | 3 | 1 | 0 | €52.00 | €52.20 | 0.387% |
| Cara Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.73 | €4.63 | 531.555% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €61.00 | €79.55 | 30.417% |
| Akebia Therapeutics Inc. | 8 | 2 | 1 | 0 | €1.15 | €3.64 | 217.456% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.59 | - | - |
| Affimed N.V. | 8 | 6 | 0 | 0 | €0.55 | €6.54 | 1083.165% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €123.00 | €150.00 | 21.951% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €3.88 | €34.41 | 786.923% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.00 | - | - |
| M1 Kliniken AG | 2 | 0 | 0 | 0 | €16.60 | - | - |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| BeiGene Ltd ADR | 9 | 1 | 2 | 0 | €148.00 | €241.54 | 63.205% |
| AC Immune Ltd | 4 | 0 | 1 | 0 | €3.10 | €14.55 | 370.023% |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.59 | €6.00 | 67.131% |
| Agilent Technologies Inc. | 17 | 3 | 0 | 0 | €139.00 | €134.50 | -3.236% |